March 12-14, 2020 | Banff, Alberta
June 9-12, 2020 | Ottawa, Ontario
The current outbreak of atypical pneumonia in Wuhan, China caused by a novel Coronavirus is being monitored closely by the SOGC Infectious Disease Committee. Historically, pregnant women have been disproportionately affected by respiratory illnesses. As seen in the influenza epidemic in 1918, the Asian flu epidemic in 1957/58, H1N1 pandemic in 2009 and the Severe Acute Respiratory Syndrome (SARS) in 2003, respiratory infections in pregnant women have higher rates of mortality, ICU admission and other infectious morbidity compared to the non-pregnant population (1, 2, 3). The more recent SARS outbreak in 2003 (another coronavirus) provides limited data in pregnancy but outcomes again appeared to be worse for pregnant women with a 28% vs 10% mortality rate (pregnant vs non-pregnant) and 57% vs 20% (pregnant vs non-pregnant) mechanical ventilation rate (4). A single case was formally reported in Canada with no adverse outcomes (5). There were no cases of maternal to fetal transmission in the SARS outbreak.
At this point in time, there is limited data available on the novel Coronavirus from Wuhan in general and no pregnancy specific data. Any febrile respiratory illness in pregnancy should be taken seriously with appropriate diagnostics and therapies targeted at the most common causes of serious respiratory infection including bacterial and viral pneumonia, such as influenza. Women with a history of symptoms within 14 days of travel from the Wuhan region in China should have novel Coronavirus considered as a possible cause. Importantly this outbreak serves as a reminder to obstetric care providers of the need to practice good infection control practices including appropriate isolation and contact/droplet or airborne precautions as per local practices and guidelines.
The SOGC Infectious Disease committee will continue to follow the outbreak and provide its members and the obstetric community with updates as more information is gathered.
More information from the Government of Canada:
Health Canada is advising Canadians that there is a risk of congenital malformations in a fetus exposed to GILENYA. Available human data (post-marketing data and pregnancy registry information) suggest that the use of GILENYA is associated with an increased risk of overall major congenital malformation (approximately 5%) when administered during pregnancy in comparison with the prevalence observed in the general population (2-4%).
See full alert here.
Health Canada Advisory: Duchesnay Inc. recalls certain lots of PregVit and PregVit folic 5 prenatal and postpartum vitamin-mineral supplements because of a packaging error
Health Canada is advising Canadians that Duchesnay Inc. is recalling certain lots of PregVit vitamin-mineral supplements (for prenatal and postpartum use) and PregVit folic 5 vitaminmineral supplements (for prenatal use) because blister packages may contain all pink (morning) tablets instead of the correct combination of pink and blue (evening) tablets. The company estimates the issue affects a very small number of products in certain lots (see the table below) and not all products.
There are no quality, safety or effectiveness concerns with the tablets themselves but there is the potential that patients may not take the proper combination of pink and blue tablets if they have received products impacted by the packaging error.
The pink and the blue tablets do not contain the same active ingredients. Women taking all pink tablets will not receive the intended vitamin and mineral supplements. In particular, the pink tablets do not contain folic acid, which is important for the healthy growth of an unborn baby and helps to reduce some types of birth defects called neural tube defects.
Properly packaged products should contain two blister packs, with each blister pack containing 15 pink tablets and 15 blue tablets. The company received a complaint of a product containing a blister pack that contained all pink tablets and no blue tablets.
Who is affected
Women who have bought or are using the affected products.
PregVit Format 60
What consumers should do
Additional information for pharmacists
What Health Canada is doing
Health Canada is monitoring the recall and verifying that the company has effectively addressed the packaging issue. Should additional safety concerns be identified, Health Canada will take appropriate action and inform Canadians as necessary.
PregVit – box
The SOGC is one of Canada’s oldest national specialty organizations. Established in 1944, the Society’s mission is to promote excellence in the practice of obstetrics and gynaecology and to advance the health of women through leadership, advocacy, collaboration, and education.
The SOGC has over 4,000 members, comprised of obstetricians, gynaecologists, family physicians, nurses, midwives, and allied health professionals working in the field of sexual reproductive health.
Sign in to take advantage of this member benefit or join the SOGC to enjoy the Journal by
clicking on ‘Become a Member’ below.
Become a Member
ALARM was developed by obstetricians/gynaecologists, family physicians, midwives and nurses, who jointly continue to maintain and teach the course. Backed by the SOGC, the ALARM course arose out of our work to improve the care provided to women, babies, and families during pregnancy, labour, and postpartum.
Please note that there are upcoming ALARM courses planned that are not yet listed below. They will be added as soon as logistical aspects are finalized.
If you would like to hold an ALARM course in your community, please contact us at firstname.lastname@example.org. Please note that a minimum of 12 participants is required.
Should you have any questions about your registration, please do not hesitate to contact us at email@example.com.
Richmond, BC - offered in English only
Sunday May 17, 2020
Please submit your application prior to February 28, 2020 for consideration,
Selected candidates will be invited to register for the course after the deadline.
Should you have any questions about your application, please do not hesitate to contact us at firstname.lastname@example.org.
The SOGC is the leading voice in women's health in Canada. We are a strong and vibrant society with an active and growing membership. We are here to support you in providing the best care possible to women in Canada and around the world. That's why so many health care providers have become members of the SOGC. Let us be your partner in practice.
The SOGC believes that good healthcare is built upon many partnerships and that improving healthcare requires a collaborative, holistic approach.
Providing the public with the information needed to make informed health decisions removes one barrier to improved health.
No content found
The SOGC Brand Recognition Program aims to assist Canadian consumers to make informed choices when selecting over-the-counter products.